Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-05-18T14:00:42.132Z Has data issue: false hasContentIssue false

Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?

Published online by Cambridge University Press:  24 September 2015

J. M. G. Gomes*
Affiliation:
Instituto Federal do Sudeste de Minas Gerais – Campus Barbacena, Rua Monsenhor José Augusto, 204, Bairro São José, Barbacena, Minas Gerais CEP 36205-018, Brazil
J. A. Costa
Affiliation:
Nutrition and Health Department, Federal University of Viçosa (Universidade Federal de Viçosa), Avenida PH Rolfs, s/n, Viçosa, Minas Gerais CEP 36570-000, Brazil
R. C. Alfenas
Affiliation:
Nutrition and Health Department, Federal University of Viçosa (Universidade Federal de Viçosa), Avenida PH Rolfs, s/n, Viçosa, Minas Gerais CEP 36570-000, Brazil
*
*Corresponding author: J. M. G. Gomes, fax +55 31 389 92541, email junia.geraldo@ufv.br
Rights & Permissions [Opens in a new window]

Abstract

Evidence from animal and human studies has associated gut microbiota, increased translocation of lipopolysaccharide (LPS) and reduced intestinal integrity (II) with the inflammatory state that occurs in obesity and type 2 diabetes mellitus (T2DM). Consumption of Ca may favour body weight reduction and glycaemic control, but its influence on II and gut microbiota is not well understood. Considering the impact of metabolic diseases on public health and the role of Ca on the pathophysiology of these diseases, this review critically discusses possible mechanisms by which high-Ca diets could affect gut microbiota and II. Published studies from 1993 to 2015 about this topic were searched and selected from Medline/PubMed, Scielo and Lilacs databases. High-Ca diets seem to favour the growth of lactobacilli, maintain II (especially in the colon), reduce translocation of LPS and regulate tight-junction gene expression. We conclude that dietary Ca might interfere with gut microbiota and II modulations and it can partly explain the effect of Ca on obesity and T2DM control. However, further research is required to define the supplementation period, the dose and the type of Ca supplement (milk or salt) required for more effective results. As Ca interacts with other components of the diet, these interactions must also be considered in future studies. We believe that more complex mechanisms involving extraintestinal disorders (hormones, cytokines and other biomarkers) also need to be studied.

Type
Full Papers
Copyright
Copyright © The Authors 2015 

Ca is the major mineral component of the skeletal system, and it is also an essential nutrient required for blood clotting, nerve conduction and muscle contraction, besides being essential for endocrine and hormone secretion( Reference Miller, Jarvis and McBean 1 ). In adults, adequate Ca intake, as recommended in the dietary reference intakes, seems to prevent obesity( Reference Ferreira, Torres and Sanjuliani 2 ) and type 2 diabetes mellitus (T2DM)( Reference Pittas, Lau and Hu 3 ). Possible mechanisms involving Ca that may favour weight and glycaemic control are still not well understood. The results of in vitro and animal studies suggest that low-Ca diets increase calcitriol (1,25-dihydroxyvitamin D) and parathormone concentrations, resulting in Ca influx into adipocytes. Increased intracellular Ca2+ activates lipogenesis (mediated by fatty acid (FA) synthase) and suppresses lipolysis (hormone-sensitive lipase), increasing body fat and inducing insulin resistance (IR)( Reference Zemel, Shi and Greer 4 ). Calcitriol also inhibits the expression of adipocyte uncoupling protein 2, reducing mitochondrial FA transport and lipid oxidation( Reference Zemel, Shi and Greer 4 ). Another possible mechanism is the interaction between dietary Ca and FA in the gut, forming insoluble Ca FA soaps, which in turn increases faecal fat excretion and reduces dietary energy( Reference Jacobsen, Lorenzen and Toubro 5 ).

Influx of Ca2+ into muscle cells promotes GLUT4 translocation and, hence, increases glucose uptake and insulin sensitivity in skeletal muscle( Reference Youn, Gulve and Holloszy 6 ). A moderate influx of Ca into pancreatic β-cells is essential for converting proinsulin to insulin and promoting insulin release( Reference Gilon, Chae and Rutter 7 ). In healthy adults, Ca supplementation increased the concentrations of gastrointestinal insulinotropic hormones, especially glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1)( Reference Trautvetter and Jahreis 8 ), and hence increased insulin sensitivity indirectly.

The beneficial effects of Ca ingestion could be associated with intestinal microbiota modulation and with increased integrity of the intestinal mucosa, as the results of human and animals’ studies indicate the importance of these intestinal parameters on obesity and diabetes development( Reference Cani, Bibiloni and Knauf 9 Reference Moreno-Indias, Cardona and Tinahones 14 ). Gut microbiota constitutes an important factor that affects nutrient absorption, energy homoeostasis, body weight control and IR( Reference Frazier, DiBaise and McClain 13 ). Intestinal permeability can be defined as the property that allows solute and fluid exchange between the intestinal lumen and the tissues( Reference Odenwald and Turner 15 ). Gut barrier is a functional unit that prevents this exchange, composed of gut microbiota, mucus, polarised epithelial cell membrane, tight junctions and the innate and adaptive immune cells forming the gut-associated lymphoid tissue( Reference Odenwald and Turner 15 Reference Lopetuso, Scaldaferri and Bruno 18 ). Integrity of these barrier structures is essential to maintain normal intestinal permeability( Reference Lopetuso, Scaldaferri and Bruno 18 ). When the intestinal barrier is unimpaired, permeability is highly selective, avoiding the entrance of undesirable solutes, pathogenic microorganisms and toxins to the blood stream( Reference Natividad and Verdu 16 Reference Lopetuso, Scaldaferri and Bruno 18 ). Integrity breakdown and increased intestinal permeability have been associated with obesity and diabetes aetiopathogenic mechanisms through the activation of proinflammatory pathways( Reference Cani, Bibiloni and Knauf 9 , Reference Wu, Ma and Han 12 , Reference Musso, Gambino and Cassader 19 ).

In animal studies, increased intestinal permeability caused metabolic endotoxaemia (measured by the translocation of bacterial lipopolysaccharide (LPS) derived from gram-negative intestinal microbiota into the peripheral circulation), low-grade inflammation and glucose intolerance( Reference Cani, Bibiloni and Knauf 9 , Reference Cani, Amar and Iglesias 20 ). Studies have shown differences in gut microbiota composition and higher concentrations of circulating endotoxins when obese and/or diabetic subjects are compared with lean and normoglycaemic ones( Reference Natividad and Verdu 16 , Reference Ley, Turnbaugh and Klein 21 Reference Jayashree, Bibin and Prabhu 23 ).

Considering the low-Ca consumption by industrialised populations( Reference Imamura, Micha and Khatibzadeh 24 ) and the increase in the worldwide prevalence of obesity and T2DM, this review aims to discuss the influence of dietary Ca on gut microbiota composition and intestinal integrity (II) in order to elucidate a possible therapeutic strategy for the prevention and/or treatment of obesity and T2DM.

Methods

Medline/PubMed, Scielo and Lilacs were searched using the following terms: calcium, dairy food, gut or intestinal or gastrointestinal microbiota, gut or intestinal or gastrointestinal barrier, gut or intestinal or gastrointestinal permeability, lipopolysaccharide, endotoxins, metabolic endotoxemia, tight junction. For data searches, the terms in English, Spanish or Portuguese were used either alone or in association. Review and original studies published from 1993 to 2015 were selected according to their titles and abstracts. In vitro studies were excluded. Each selected manuscript was critically analysed.

Gut microbiota and intestinal integrity: how might dietary calcium work?

Human gut microbiome may be affected by short-term (about a few days) dietary Ca intake( Reference David, Maurice and Carmody 25 ). Dietary Ca may affect gut microbiota and II through mechanisms involving gastric acid secretion, bile acid (BA) and FA precipitation, competition among intestinal bacterial communities and changes on fermentation products in the colon and on intestinal mucosal integrity (Fig. 1). Online Supplementary Table S1 briefly describes studies that evaluated the effects of Ca supplementation on II in animals and humans.

Fig. 1 Possible mechanisms explaining the effects of high-calcium diets on intestinal integrity and gut microbiota. High-calcium diets seem to change the intestinal environment through the following mechanisms: (1) increasing gastric secretion leading to increased gastric pH and reduced number of viable bacteria; (2) causing bile acid and fatty acid precipitation, increasing colonic pH and reducing cytotoxic components (especially NEFA and ionised secondary bile acids) that damage the epithelial cells; and (3) increasing glucagon-like peptide-2 (GLP-2) secretion, which has a trophic effect on intestinal mucosa and reduces gene expression of tight junctions (occludin and zonula occludens-1). These mechanisms may reduce bacterial and lipopolysaccharide (LPS) translocation, by bacterial fermentation and intestinal microbiota modulation, leading to a highly selective and controlled intestinal permeability.

Antimicrobial effect of gastric acid secretion

High-Ca diets (30 mmol Ca/l( Reference Bovee-Oudenhoven, Termont and Dekker 26 ) and 180 mmol Ca/kg diet( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 )) are associated with reduced number of viable bacteria in the stomach. A high intraluminal concentration of Ca2+ stimulates the release of gastrin and, consequently, increases acid secretion( Reference Kopic and Geibel 28 ). Several bacterial species (e.g. Salmonella) are destroyed by gastric acid( Reference Álvarez-Ordóñez, Begley and Prieto 29 ). However, some factors, such as the buffering effect of food, gastric emptying rate and mechanisms of bacterial resistance, interfere with the interaction of gastric acid and ingested bacteria( Reference Sarker and Gyr 30 ). Wistar rats (n 9 per group) were fed ad libitum for 12 d a low-Ca diet (control: lactose-free low-Ca milk, 3·8 % fat, 6 mmol Ca/l), regular lactose-free milk (3·7 % fat, 30 mmol Ca/l), acidified milk or yoghurt (both prepared with regular lactose-free milk)( Reference Bovee-Oudenhoven, Termont and Dekker 26 ). These rats were orally infected with Salmonella enteritidis just after food consumption. Animals fed yoghurt had lower faecal excretion of bacteria than those in the other groups. The authors suggest that the lower gastric emptying rate after yoghurt consumption could have prolonged the exposure to gastric acid and, thus, reduced the effectiveness of the inoculation. Thereafter, faecal Salmonella excretion declined rapidly in all high-Ca groups compared with the control group( Reference Bovee-Oudenhoven, Termont and Dekker 26 ). Another study conducted by the same authors showed similar results( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 ). Mice infected with S. enteritidis were fed high-, medium- or low-Ca diets (n 8 per group; Ca in the form of CaHPO4: 180, 60 and 20 mmol/kg diet, respectively). Compared with the low-Ca diet, the medium- and high-Ca diets favoured bacterial colonisation( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 ). High-Ca intake (30 mmol Ca/l( Reference Bovee-Oudenhoven, Termont and Weerkamp 2 6) and 180 mmol Ca/kg diet( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 )) probably increased the gastric acidity and, hence, reduced viable counts of S. enteritidis ( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Bovee-Oudenhoven, Termont and Weerkamp 27 ). Other studies also showed the antimicrobial effect of gastric acid( Reference Álvarez-Ordóñez, Begley and Prieto 29 , Reference Zhu, Hart and Sales 31 ), which potentially modified the endogenous microbiota by reducing viable bacteria in the gut. In general, few microorganisms, such as Helicobacter pylori, some streptococci, lactobacilli and probiotics, can survive extremely acidic conditions within the stomach( Reference Berg 32 , Reference Dicksved, Lindberg and Rosenquist 33 ). However, in some studies( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Bovee-Oudenhoven, Termont and Weerkamp 27 ), gastrin release and/or acid secretion were not measured. Therefore, we cannot conclude that the results of those studies( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Bovee-Oudenhoven, Termont and Weerkamp 27 ) were mediated by changes in gastric secretion. High protein content and the liquid state of the diets facilitated bacterial survival within the stomach( Reference Álvarez-Ordóñez, Begley and Prieto 29 ). Furthermore, some dairy product components, such as Ig, peptides, lactoferrin, lactoperoxidase and lysozyme, have antimicrobial effects. Other dairy components such as lactose, peptides and probiotics stimulate potentially beneficial bacteria that compete with pathogens for nutrients and attachment, and enhance the mucosal immune response to pathogens( Reference Mills, Ross and Hill 34 , Reference Venema 35 ).

Bile acid and fatty acid precipitation: reducing luminal cytotoxicity

Because of the low pH, dietary Ca in the stomach exists in dissociated form, whereas in the small intestine there is an equilibrium between its dissociated and nondissociated forms. In the distal ileum and the colon, where pH>6, Ca interacts with dietary phosphate, forming an insoluble complex that precipitates intestinal BA and FA. Hence, Ca increases their faecal excretion in animals( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 , Reference Lapré, De Vries and Koeman 36 Reference Bovee-Oudenhoven, Wissink and Wouters 38 ) and humans( Reference Van der Meer, Welberg and Kuipers 39 Reference Zheng, Yde and Clausen 44 ). BA precipitation increases the de novo synthesis of BA from cholesterol in the liver and, hence, reduces serum cholesterol. FA precipitation reduces fat absorption, increasing faecal energy loss( Reference Jacobsen, Lorenzen and Toubro 5 ).

Primary BA (cholic acid and chenodeoxycholic acid) are synthesised in the liver from cholesterol and then conjugated with either glycine or taurine, often called bile salts. About 5 % of BA are deconjugated and dehydroxylated by bacterial enzymes in the intestine to form secondary BA (deoxycholic acid and lithocholic acid), which are more cytotoxic. The dehydroxylation process involves the removal of the OH group at the 7-position of the steroid nucleus (also termed 7-dehydroxylation). Deconjugation results in amino acid side chain cleavage. Among intestinal bacteria, 7-dehydroxylase was detected in the Eubacterium and Clostridium genera but not in lactobacilli and bifidobacteria( Reference Begley, Gahan and Hill 45 , Reference Floch 46 ). BA hydrolysis is mediated by several gut microbiota genera, including Clostridium, Bacteroides, Lactobacillus, Bifidobacterium and Enterococcus ( Reference Begley, Gahan and Hill 45 ). Approximately 95 % of BA are reabsorbed in the distal ileum and return to the liver (enterohepatic circulation of BA). About 400–800 mg BA/d elude enterohepatic circulation and are subjected to extensive modifications by the endogenous colonic microbiota. Secondary BA formed by colonic bacteria can be absorbed passively and, thus, may contribute to the BA pool( Reference Kopic and Geibel 28 ).

A small amount of NEFA and ionised secondary BA that reaches the colon can damage the intestinal epithelium and thus increase colonic permeability( Reference Schepens, ten Bruggencate and Schonewille 47 ). Therefore, BA and FA precipitation caused by dietary Ca promotes cytoprotective effects by reducing the bacteria’s formation of cytotoxic surfactants. BA and FA precipitation ultimately maintains the integrity of the colonic epithelium.

Measuring the BA and FA concentrations in the soluble portion of the faeces (so-called faecal water (FW)) is more reflective of luminal cytotoxicity than measuring the total faecal BA and FA concentration( Reference Roberton 48 ). FW refers to the supernatant obtained after intense centrifugation of the faeces. FW contains aqueous soluble BA and FA that are not linked to other faecal compounds( Reference Lapré, Termont and Groen 49 ). In some studies, a high-Ca diet reduced the BA and FA concentration in FW( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Bovee-Oudenhoven, Termont and Weerkamp 27 , Reference Lapré, De Vries and Koeman 36 Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Govers and Van der Meer 40 , Reference Govers, Termont and Lapre´ 41 ). A high-Ca diet also reduced FW cytotoxicity by precipitating cytotoxic surfactants, resulting in lower colonic epithelium damage and higher resistance to infections( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Bovee-Oudenhoven, Termont and Weerkamp 27 , Reference Lapré, De Vries and Koeman 36 Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Govers and Van der Meer 40 , Reference Govers, Termont and Lapre´ 41 , Reference Schepens, ten Bruggencate and Schonewille 47 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 Reference Van Ampting, Schonewille and Vink 52 ). High-Ca diets contained 30 mmol/l( Reference Bovee-Oudenhoven, Termont and Dekker 26 ), 225 μmol/g diet( Reference Lapré, De Vries and Koeman 36 , Reference Govers and Van der Meer 40 ), 120( Reference Schepens, ten Bruggencate and Schonewille 47 , Reference Schepens, Schonewille and Vink 51 ), 150( Reference Govers, Termont and Van der Meer 37 ) or 180( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 , Reference Bovee-Oudenhoven, Wissink and Wouters 38 ) mmol/kg diet and 4·8 g/kg diet( Reference Van Ampting, Schonewille and Vink 52 ) in the rats studies, and 1200 mg/d in the human study( Reference Govers, Termont and Lapre´ 41 ). Some effects of cytotoxic surfactants are cell membrane disruption, inflammatory reaction activation and epithelium hyperproliferation enhancement( Reference Imamura, Micha and Khatibzadeh 24 , Reference Berg 32 , Reference Ajouz, Mukherji and Shamseddine 53 ). Guarner( Reference Guarner 54 ) criticised the use of erythrocytes instead of intestinal epithelial cells to analyse FW cytotoxicity, as done in some studies( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Bovee-Oudenhoven, Termont and Weerkamp 27 , Reference Lapré, De Vries and Koeman 36 Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Govers and Van der Meer 40 , Reference Govers, Termont and Lapre´ 41 , Reference Schepens, ten Bruggencate and Schonewille 47 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 Reference Van Ampting, Schonewille and Vink 52 ). Erythrocytes are susceptible to changes in pH resulting from the production of SCFA after the fermentation of non-digestible carbohydrates. Therefore, haemolysis caused by changes in pH by SCFA may not reflect epitheliolysis( Reference Guarner 54 ). On the other hand, intestinal cells normally use organic acids as an energy source( Reference Guarner 54 ). However, the erythrocyte assay has previously been validated( Reference Lapré, Termont and Groen 49 ). In a mouse study, the type of dietary fat influenced faecal FA excretion. Ca-PUFA soaps were more soluble and, therefore, better absorbed than Ca-saturated FA soaps( Reference Lapré, De Vries and Koeman 36 ). The decreased absorption of intestinal fat (mainly saturated fat) caused by dietary Ca is of interest for the improvement of obesity control. By contrast, FA precipitation was independent of the source of Ca (milk, calcium carbonate or calcium phosphate)( Reference Govers, Termont and Van der Meer 37 ) and dietary phosphate content (75, 125 or 275 mmol/g diet)( Reference Govers and Van der Meer 40 ).

Increased faecal fat excretion after Ca supplementation seems to favour weight control. An average daily intake of 1200 mg of Ca results in the excretion of 5·2 g fat/d and a weight loss of 2·2 kg/year( Reference Christensen, Lorenzen and Svith 55 ). Therefore, it is possible that this mechanism contributes to obesity control but does not fully explain the effect of Ca on weight loss( Reference Jacobsen, Lorenzen and Toubro 5 ). We believe that the impact of dietary Ca on weight loss is also related to dysbiosis attenuation. In this context, a high-Ca diet (>1100 mg/d) seems to modulate gut microbiota by reducing the number of BA and FA available for bacterial metabolism. It is possible that this effect increases Lactobacillus and reduces bile-tolerant bacteria, as discussed below.

Resistance to pathogens and changes in gut microbiota composition

In rodents, high-calcium phosphate diets increased faecal lactobacilli excretion( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Van Ampting, Schonewille and Vink 52 ), reduced faecal Enterobacteriaceae excretion( Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Ten Bruggencate, Snel and Schoterman 56 ) and increased resistance to S. enteritidis after 6–7 d of infection( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Van Ampting, Schonewille and Vink 52 , Reference Ten Bruggencate, Snel and Schoterman 56 ). Ca concentrations of these diets were previously mentioned( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Van Ampting, Schonewille and Vink 52 ), except the concentration adopted in the study conducted by Ten Bruggencate et al.( Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Ten Bruggencate, Snel and Schoterman 56 ), which was 100 mmol Ca/kg diet. Rats were fed diets with 60 g/kg cellulose (control), fructo-oligosaccharides (FOS) or inulin with either a low (30 mmol/kg) or a high (100 mmol/kg) Ca concentration. After 2 weeks of adaptation, the animals were infected with S. enteritidis. During the following 6 d, FW cytotoxicity increased in the rats on inulin and FOS diets, but the high-Ca diet minimised this adverse effect( Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 ). In another study, rats infected with S. enteritidis were fed different sources of Ca supplements (calcium phosphate, milk Ca, calcium chloride or calcium carbonate (a total of 100 mmol Ca supplement/kg)) or a low-Ca diet (20 mmol calcium phosphate/kg). After an adaptation period of 2 weeks, all the Ca supplements reduced infection and increased resistance to Salmonella ( Reference Ten Bruggencate, Snel and Schoterman 56 ). Effects of Ca salts were similar to milk Ca( Reference Ten Bruggencate, Snel and Schoterman 56 ), suggesting a strategy to increase Ca intake in cases of restricted consumption of dairy foods – for example, lactose intolerance.

The authors suggest that the resistance to pathogens was because of BA and FA precipitation and, consequently, because of reduced cytotoxic surfactants in FW after calcium phosphate supplementation( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Van Ampting, Schonewille and Vink 52 , Reference Ten Bruggencate, Snel and Schoterman 56 ). However, only Bovee-Oudenhaven et al.( Reference Bovee-Oudenhoven, Wissink and Wouters 38 ) evaluated BA and FA faecal excretion. gram-negative bacteria (such as Escherichia coli and Salmonella spp.) are more bile-tolerant than gram-positive bacteria (such as some species of bifidobacteria, Bacillus, Lactobacillus and Enterococcus)( Reference Begley, Gahan and Hill 45 ). Therefore, the reduction in cytotoxicity in the intestinal lumen (reduction in the lytic activity of luminal surfactants), induced by dietary calcium phosphate, could improve the growth of Lactobacillus and other gram-positive bacteria compared with that of gram-negative bacteria.

Another mechanism by which dietary calcium phosphate interferes with resistance to pathogens is by binding directly to Salmonella and, hence, increasing the excretion of faecal bacteria, which is also known as bacterial shedding. This reduces pathogen competition and thus enhances the growth of lactobacilli. In vitro,( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Ten Bruggencate, Snel and Schoterman 56 ) but not vivo,( Reference Van Ampting, Schonewille and Vink 52 ) studies confirmed this mechanism. In an in vivo study( Reference Van Ampting, Schonewille and Vink 52 ), rats (n 8 per group) infected with Salmonella were treated with an antibiotic and were either fed the control diet (1·2 g/kg diet) or a high-Ca diet (4·8 g/kg diet). Both diets did not decrease Salmonella colonisation (measured by the excretion of faecal bacteria). The authors rejected the hypothesis that the binding of the calcium phosphate complex to Salmonella has a significant effect in vivo and, therefore, suggested that surfactant precipitation may increase endogenous microbiota.

Research on pigs showed different effects of calcium phosphate in intestinal lactobacilli colonisation. In general, high-calcium phosphate intake did not affect Lactobacillus spp. growth( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ) in the pigs’ stomachs, ilea or colons. Only in the study by Mann et al.( Reference Mann, Schmitz-Esser and Zebeli 60 ) did high- v. adequate-calcium phosphate diets increase Lactobacillus spp. growth in the stomach. These studies were performed with growing( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 ) or weaned( Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 Reference Mann, Schmitz-Esser and Zebeli 60 ) pigs (n 8 per group) fed high-calcium phosphate diets: with an ileal pectin infusion( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 ), with a high or low β-glucan content( Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 ), associated with a corn diet, or associated with a wheat–barley diet( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 , Reference Mann, Schmitz-Esser and Zebeli 60 ). High-calcium phosphate diets contained 15 g Ca/kg diet( Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 ), 10 g Ca/kg diet( Reference Schepens, Schonewille and Vink 51 ) and 14·8 g Ca/kg diet( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 , Reference Mann, Schmitz-Esser and Zebeli 60 ). The main difference between these pig studies that explain the changes in gastrointestinal microbiota was the methodology used to quantify bacterial communities. Studies in which no effects on lactobacilli count were observed used quantitative PCR( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ), whereas Mann et al.( Reference Mann, Schmitz-Esser and Zebeli 60 ) used the pyrosequencing of 16S rRNA genes. Because of the diversity and complexity of bacterial communities between species, the latter technique has been recommended. It has the capacity to sequence multiple fragments simultaneously and, thus, achieves more rapid and accurate bacterial genome sequences( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 , Reference Kim, Suda and Kim 61 ). Although some authors criticise pyrosequencing for the phylogenetic classification of sequences obtained at the species level( Reference Kim, Suda and Kim 61 ), Mann et al.( Reference Mann, Schmitz-Esser and Zebeli 60 ) did not use it for pyrosequencing the total genome; rather, they only used it for the 16S rRNA gene. Thus, they demonstrated increases on operational taxonomic units for Lactobacillus, indicating an increase in the number of microorganisms of this genus. This is extremely beneficial because of the effects of these bacteria on intestinal health.

Calcium phosphate diet modulated gastrointestinal microbiota in all pig studies, but the results were very different. Because of that, these studies will not be described in detail (see online Supplementary Table S1). In general, calcium phosphate intake over 14 d increased Clostridium cluster XI and XVIa in the ilea, caeca and colons of weaned pigs( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 Reference Mann, Schmitz-Esser and Zebeli 60 ). Several species of Clostridium cluster IV and XIVa produce butyrate, which is an important energy source for colonocytes( Reference Louis and Flint 62 ).

A double-blind, placebo-controlled, crossover study evaluated the composition of the gut microbiota after calcium phosphate and probiotic supplementation in humans( Reference Trautvetter, Ditscheid and Kiehntopf 43 ). Participants (thirty-two healthy men and women aged 25 (sd 5) years and BMI of 22 (sd 3) kg/m2) consumed a probiotic drink containing 1010 colony-forming unit (CFU)/d Lactobacillus paracasei alone or in combination with bread containing calcium phosphate (1 g/d) for 4 weeks. Calcium phosphate supplementation decreased total cholesterol, LDL-cholesterol and the LDL:HDL ratio, and increased faecal pH and the faecal excretion of secondary BA compared with supplementation with probiotics or placebo alone. Probiotic supplementation, alone or with calcium phosphate, increased faecal Lactobacillus excretion. The authors explained these effects as resulting from BA precipitation by amorphous calcium phosphate, particularly when BA are deconjugated by probiotics, and from the increased faecal excretion of these components. A less cytotoxic intestinal lumen, which contains a low concentration of cytotoxic surfactants, might favour the growth of lactobacilli and reduce blood cholesterol concentration because of the increased conversion of cholesterol into BA( Reference Trautvetter, Ditscheid and Kiehntopf 43 ).

The results of the studies with mice, pigs and humans are difficult to compare because of the diversity of micro-organism species in different hosts. Within the same species (mouse, pig or man), the intestinal maturation stage can also influence gut microbiota composition. For instance, Enterococcus spp. in the ileum were observed to decrease and increase in growing and weaned pigs, respectively, after calcium phosphate supplementation( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 , Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ). In humans, gut microbiota is dominated by bifidobacteria in the first 2–3 years of life (especially among breastfed children), remaining relatively stable in adults with 90 % of the bacteria from the Bacteroidetes and Firmicutes phyla. In the elderly, gut microbiota becomes less diverse again (higher Bacteroides:Firmicutes ratio, an increase in Proteobacteria and a decrease in Bifidobacterium)( Reference Ottman, Smidt and de Vos 63 ). Human gut microbiota also varies according to genetic background, diet, antibiotic use and the health status of the host( Reference Nicholson, Holmes and Kinross 64 ). Therefore, the interaction between Ca and other dietary nutrients (such as lactose, dietary fibre and probiotics) probably influences its effect on microbiota composition and activity.

Furthermore, the different results observed may be because of the variety of procedures used on microbiological analyses. These range from simple techniques such as counting CFU in mouse studies( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Van Ampting, Schonewille and Vink 52 ) to sophisticated molecular biology techniques such as quantitative PCR and pyrosequencing 16S rRNA genes in pig and human studies( Reference Trautvetter, Ditscheid and Kiehntopf 43 , Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 Reference Mann, Schmitz-Esser and Zebeli 60 ). The variety in materials or parts of the gastrointestinal tract used to evaluate microbiota composition may also make comparisons difficult. Mouse and human studies used faeces( Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Trautvetter, Ditscheid and Kiehntopf 43 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Van Ampting, Schonewille and Vink 52 ), whereas pig studies used different viscera (stomachs, small intestines, caeca and colons)( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 Reference Mann, Schmitz-Esser and Zebeli 60 ).

Differences between BA in mice (predominantly taurine-conjugated) and those in pigs (glycine-conjugated) also partly explain the diversity in results. In general, unconjugated BA and glycine-conjugated BA are more strongly precipitated by calcium phosphate than taurine-conjugated BA( Reference Bovee-Oudenhoven, Wissink and Wouters 38 ). The taurine-conjugated:glycine-conjugated BA ratio in human bile is usually 3:1, which is more similar to that in pigs than to that in rodents( Reference Begley, Gahan and Hill 45 ).

Obesity is associated with changes in gut microbiota composition in animal and human research( Reference Cani, Possemiers and Van de Wiele 10 , Reference Ridaura, Faith and Rey 65 ). Some studies show an increase in the Firmicutes:Bacteroidetes ratio( Reference Ley 66 ), and others only show an overall decrease in Bacteroidetes and no change in Firmicutes( Reference Turnbaugh, Hamady and Yatsunenko 22 ). There are also differences between the gut microbiota of obese and lean subjects( Reference Ridaura, Faith and Rey 65 ). However, it is not yet clear whether obesity leads to dysbiosis or vice versa. If the effects of dietary Ca on lactobacilli growth are confirmed in human clinical trials, Ca supplementation will be a useful strategy in obesity treatment.

Change in faecal pH and in fermentation products

Most mouse( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Schepens, Rijnierse and Schonewille 67 ) and human( Reference Govers, Termont and Lapre´ 41 , Reference Trautvetter, Ditscheid and Kiehntopf 43 ) studies have found an increase in faecal pH after high-Ca diets (30 mmol Ca/l( Reference Bovee-Oudenhoven, Termont and Dekker 26 ), 100( Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 ) and 120( Reference Schepens, Rijnierse and Schonewille 67 ) mmol Ca/kg diet in mouse studies, and 1000( Reference Trautvetter, Ditscheid and Kiehntopf 43 ) or 1200 Ca mg/d( Reference Govers, Termont and Lapre´ 41 ) in human studies). Other mouse studies( Reference Lapré, De Vries and Koeman 36 ), as well as pig studies( Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 , Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ), did not reveal such differences, and only one study showed a decrease in faecal pH as a result of Ca supplementation( Reference Govers, Termont and Van der Meer 37 ) (225 μmol Ca/g diet( Reference Lapré, De Vries and Koeman 36 ), 10( Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 ) or 14·8( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ) g Ca/kg diet, and 1 g/d( Reference Govers, Termont and Van der Meer 37 )). The decrease in faecal pH, caused by products of the colonic fermentation of non-digestible carbohydrates, supports the growth of beneficial bacteria (particularly bifidobacteria and lactobacilli)( Reference Fooks and Gibson 68 ). As previously mentioned, dietary Ca is soluble in acids, and it precipitates at alkaline pH. Gastric acidity (pH 1–3) is sufficient to release Ca complexed to salts or foods. Thus, the ionised Ca can be absorbed via transcellular active transport in the duodenum and proximal jejunum and via a passive paracellular process throughout the ileum. Less than 10 % of Ca absorption occurs in the colon, and it involves the paracellular and transcellular pathways( Reference Bronner 69 ). About 25 to 35 % of ingested Ca is generally absorbed. As pH increases from the ileum to the colon, the intestinal phosphate concentration also increases, causing Ca precipitation and Ca absorption reduction( Reference Kopic and Geibel 28 ). Therefore, an increase in Ca intake may increase the buffering capacity of faeces because of the formation of an amorphous calcium phosphate complex. In the studies discussed in our review, the acidification caused by bacterial fermentation may have been buffered by the high amounts of calcium phosphate in the colonic lumen (quantities described in the first paragraph of this session), causing no change or increase in faecal pH( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Lapré, De Vries and Koeman 36 , Reference Govers, Termont and Lapre´ 41 , Reference Trautvetter, Ditscheid and Kiehntopf 43 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 , Reference Schepens, Rijnierse and Schonewille 67 ). The buffering effect is suggested by the increase in the faecal excretion of Ca and phosphate( Reference Lapré, De Vries and Koeman 36 , Reference Govers, Termont and Van der Meer 37 , Reference Govers, Termont and Lapre´ 41 , Reference Trautvetter, Ditscheid and Kiehntopf 43 ) and/or the decrease in BA and FA concentration in FW( Reference Bovee-Oudenhoven, Termont and Dekker 26 , Reference Lapré, De Vries and Koeman 36 , Reference Govers, Termont and Van der Meer 37 , Reference Govers, Termont and Lapre´ 41 , Reference Trautvetter, Ditscheid and Kiehntopf 43 ).

In the animal research that evaluated the effect of Ca supplementation on the products of bacterial fermentation, there was an increase in acetate in the ilea( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 ) and caproate in the colons( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ) of pigs. There was also an increase in lactate in the caeca( Reference Schepens, ten Bruggencate and Schonewille 47 ), and in propionate and butyrate in the faeces of mice( Reference Overduin, Schoterman and Calame 70 ). Metzler-Zebeli et al.( Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 ) observed a decrease in propionate in the caeca of pigs. The sources and quantities of fibre used to stimulate colonic fermentation varied among the studies (60 g pectin/d( Reference Metzler-Zebeli, Vahjen and Baumgärtel 57 ); 60 g FOS/kg diet( Reference Schepens, ten Bruggencate and Schonewille 47 ); 36 g crude fibre/kg diet( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ); 6 % (w/w) galacto-oligosaccharides( Reference Overduin, Schoterman and Calame 70 )). The use of probiotics in humans( Reference Whisner, Martin and Schoterman 71 ) and animals( Reference Weaver, Martin and Nakatsu 72 ) increases Ca absorption, especially in the colon. However, even with this increase, it is possible that much of the ingested Ca transits through the colon without being absorbed( Reference Whisner, Martin and Schoterman 71 ).

In a crossover study, isoenergetic diets with similar macronutrient compositions, rich in semi-skimmed milk (1·7 g Ca/d) or cows’ semihard cheese (1·7 g Ca/d), and ingested by fifteen healthy adult men over 14 d increased faecal SCFA (acetate, propionate and butyrate) in comparison with the control diet (which was rich in butter with approximately 360 mg Ca/d)( Reference Zheng, Yde and Clausen 44 ). In comparison with the control diet, both experimental diets increased faecal fat excretion, mainly in the milk group. Cheese intake resulted in higher faecal concentrations of propionate and butyrate, whereas milk intake promoted greater faecal excretion of acetate. These results indicate that milk and cheese stimulate bacterial activity differently. According to the authors, further studies are needed to explore the reasons for this difference. A possible interference factor is the protein profile of cheese (mainly casein, absorbed slowly) and of milk (20 % casein and 80 % whey protein, with the latter absorbed faster)( Reference Zheng, Yde and Clausen 44 ).

Colonic fermentation of fibre mainly generates lactate and SCFA. The amount and type of these metabolites formed depends on gut microbiota composition, the substrate and the intestinal transit time( Reference Van Langen and Dieleman 73 ). Acetate is produced by several groups of bacteria and comprises about 60 to 75 % of total SCFA. In addition, acetate is metabolised in peripheral tissues (through the formation of acetyl-CoA) and/or used for butyrate synthesis( Reference Van Langen and Dieleman 73 ). The number of microorganisms that can produce propionate and butyrate is low. Propionate is mainly produced by Bacteroides spp., Clostridium cluster IX, Mitsuokella and Veillonella spp.( Reference Metzler-Zebeli, Zijlstra and Mosenthin 58 ). Proprionate is metabolised in the liver via glycogenesis and is a lipolysis inhibitor and an inhibitor of the formation of acetyl-CoA from acetate( Reference Zheng, Yde and Clausen 44 ). Butyrate, an inhibitor of acetate synthesis, is the main energy source for colonocytes, followed by acetate and then propionate( Reference Zheng, Yde and Clausen 44 , Reference Pryde, Duncan and Hold 74 ). Some SCFA production, such as butyrate, is important not only as an energy source for colonocytes but it also prevents the accumulation of potentially toxic metabolites such as d-lactate. In addition, butyrate acts in visceral sensitivity and intestinal motility, regulates transcellular fluid transport, reinforces the gut barrier and reduces mucosal inflammation and oxidative stress( Reference Canani, Costanzo and Leone 75 ). Eubacterium rectale, Clostridium coccoides and Roseburia, which belong to the genus Clostridium cluster XIVa, are the largest butyrate producers( Reference Bronner 69 ). Some species of Clostridium cluster XIVa can convert lactate to butyrate, whereas some cluster IX members can convert lactate to propionate( Reference Louis, Scott and Duncan 76 ).

Lactic acid is a primary metabolite of fermentation in the caecum( Reference Van Langen and Dieleman 73 ). The production of lactic acid and SCFA lowers the pH, inhibiting the activity of microorganisms that metabolise lactate, for example, propionate-producing bacteria( Reference Duncan, Louis and Flint 77 ). Excessive lactate production culminates in its accumulation in the colon as it has low intestinal absorption( Reference Louis, Scott and Duncan 76 , Reference Duncan, Louis and Flint 77 ). Overduin et al.( Reference Overduin, Schoterman and Calame 70 ) suggest that dietary calcium phosphate supplementation influences this fermentation as the amorphous complex formed acts as a buffer against caecal acidification by lactate, thereby accelerating lactate conversion to SCFA in the caecum. According to the authors, colonocytes’ rapid uptake of butyrate may have masked SCFA production, which explains why they observed lower concentrations of butyrate in the colons of rats that had been fed prebiotics. Moreover, as lactate is less absorbable, it can accumulate in the colon in larger quantities( Reference Overduin, Schoterman and Calame 70 ).

Using the quantification of fermentation products to evaluate bacterial metabolic activity may be biased. Many of these products can act as intermediate substrates (i.e. lactate and acetate) and, therefore, may be associated with the metabolic activity of bacterial producers and/or bacterial users of these substrates. For example, an increase in lactate concentrations may indicate an increase in lactate producers or a decrease in lactate users. Therefore, it does not allow definitive conclusions. Moreover, about 95 % of the SCFA produced by bacterial fermentation are absorbed by colonocytes during the intestinal transit. Therefore, a lack in the alteration of these components may not represent real changes in the gut microbiota. Perhaps it represents the more effective use of the components, mediated by diet( Reference Overduin, Schoterman and Calame 70 , Reference Louis, Scott and Duncan 76 , Reference Duncan, Louis and Flint 77 ).

Obese subjects and animals have more SCFA in their caeca than lean ones. This seems to favour higher energy storage after the intake of non-digestible carbohydrate( Reference Ley 66 , Reference Schwiertz, Taras and Schafer 78 ) and lower intestinal transit time induced by the hormone peptide YY( Reference Musso, Gambino and Cassader 79 ). Overall, this favours weight gain. Although the effects of Ca have not been confirmed, considering the results of the studies analysed, it is possible that the increased faecal fat excretion and the modulation of gut microbiota that resulted from high-Ca diets (approximately1100 mg Ca/d in the human studies( Reference Govers, Termont and Lapre´ 41 , Reference Trautvetter, Ditscheid and Kiehntopf 43 )) counteracted these effects.

Effects on intestinal permeability and integrity

Paracellular permeability allows substance movement between adjacent cells, by a passive process. In contrast, through transcellular permeability, transport can occur across the cells, and it involves both active and passive processes( Reference Teixeira, Moreira and Silva 17 ). Several high-Ca salts (calcium phosphate, milk, calcium carbonate and calcium chloride) decreased intestinal permeability in rats (100( Reference Ten Bruggencate, Snel and Schoterman 56 ) or 120 mmol Ca/kg( Reference Schepens, ten Bruggencate and Schonewille 47 , Reference Schepens, Schonewille and Vink 51 , Reference Schepens, Rijnierse and Schonewille 67 , Reference Schepens, Vink and Schonewille 80 ), and 1·5 % Ca( Reference Rao 81 )). Most of these studies used oral administration of EDTA chromium (Cr-EDTA) as a marker of intestinal paracellular permeability( Reference Schepens, ten Bruggencate and Schonewille 47 , Reference Schepens, Schonewille and Vink 51 , Reference Schepens, Rijnierse and Schonewille 67 , Reference Schepens, Vink and Schonewille 80 , Reference Rao 81 ). As Cr-EDTA is stable throughout the gastrointestinal tract, its excretion in the urine reflects total intestinal permeability( Reference Schepens, Rijnierse and Schonewille 67 ). Sugars, such as lactulose (reflecting paracellular permeability) and mannitol (transcellular permeability), are usually ingested to measure region-specific permeability. These sugars are readily degraded by colonic microbiota. Thus, the urinary excretion rate of these sugars (lactulose:mannitol ratio) is used to express the small intestine permeability( Reference Arrieta, Bistritz and Meddings 82 ).

Compared with the control diet, high-Ca diets (quantities described in the previous paragraph) decreased Cr-EDTA urine excretion, and increased the lactulose:mannitol ratio in rats( Reference Schepens, Rijnierse and Schonewille 67 ). However, there was no statistical difference when the urinary excretion of the lactulose and that of mannitol were analysed individually. On the basis of individual lactulose results, the authors concluded that dietary Ca did not affect the permeability of the small intestine. Consequently, they questioned the relevance of the lactulose:mannitol ratio and recommended measuring the excretion of each sugar individually( Reference Schepens, Rijnierse and Schonewille 67 ). This is relevant because, in some situations in which both sugars are excreted in large or small quantities, the ratio remains unchanged( Reference Teixeira, Moreira and Silva 17 ). Obese women appear to have higher urinary excretion of lactulose and mannitol, whereas their lactulose:mannitol ratio does not vary from that of lean women( Reference Teixeira, Souza and Chiarello 83 ). The use of large probes such as lactulose is the best way to analyse macromolecule passage through the intestinal barrier, such as dietary antigens and other components derived from bacteria( Reference Teixeira, Moreira and Silva 17 ). Another relevant example involves coeliac patients, who tend to have low mannitol excretion because of villous atrophy, whereas their lactulose excretion is high. When calculating the lactulose:mannitol ratio, this information does not lead to accurate results( Reference Vilela, Torres and Ferrari 84 ). Therefore, it is suggested that Ca supplementation mainly affects colonic permeability( Reference Schepens, Rijnierse and Schonewille 67 ), which is expected, considering the previous discussion about the effects of Ca on BA and FA precipitation in the colon. This effect reduces cell damage and, consequently, increases the integrity of the epithelial mucosa.

In a transgenic animal model of colitis induction, Ca supplementation prevented colitis-induced increase in the expression of extracellular matrix remodelling genes such as matrix metalloproteinases, procollagens and fibronectin. This suggests that Ca strengthened the integrity of the colonic mucosa( Reference Schepens, Schonewille and Vink 51 ). Even in animal models, high dietary Ca (90 mmol/kg) prevented the FOS-induced increase in intestinal permeability (measured by Cr-EDTA) only when phosphate content was medium (70 mmol/kg diet) or high (160 mmol/kg diet). This was not the case with low-phosphate diets (5 mmol/kg diet). The effect was attributed to the buffering capacity of the colonic lumen because of the formation of a calcium phosphate complex, which could reduce luminal cytotoxicity. In this respect, the phosphate content of the diet is not decisive, but it is necessary for the effect of Ca on intestinal permeability( Reference Schepens, ten Bruggencate and Schonewille 47 ). Therefore, based on Schepens et al.( Reference Schepens, ten Bruggencate and Schonewille 47 ), a ratio of about 1:1·3 of Ca:P can affect colon permeability.

Extracellular Ca (luminal Ca) was essential for intestinal tight-junction maintenance( Reference Gonzalez-Mariscal, Contreras and Bolivar 85 ). Tight junctions are apical intercellular joints, which contain transmembrane proteins, cytoskeleton components and cytoplasmic plaques( Reference Gumbiner 86 ). These junctions act on cellular adhesion, intracellular signalling, protection against extracellular entrance and paracellular transportation of substances to the intestinal lumen( Reference Farquhar and Palade 87 ). Among the various tight-junction proteins, the transmembrane proteins (such as occludin and claudin) and cytoplasmic plaques (como a zonula occludens (ZO)) are important for paracellular transport( Reference Hwang, Yang and Kang 88 ). Low-Ca and/or low-vitamin D diets reduce tight-junction gene expression in calbindin-null mice( Reference Hwang, Yang and Kang 88 ), suggesting the importance of this mineral for the synthesis of tight-junction proteins and, therefore, for paracellular permeability. The intact microbiome appears to be essential for normal gut–brain axis signalling and the expression of calbindin, restoring the intrinsic and extrinsic enteric nerve function in germ-free mice, and causing changes to intracellular calbindin concentrations( Reference McVey Neufeld, Perez-Burgos and Mao 89 ). Thus, it is believed that the microbiome may contribute to improve dietary Ca absorption.

Calcium phosphate supplementation (1 g/d) during 3 weeks increased GLP-1 and GLP-2 secretion in healthy adult men (n 10) in a double-blind placebo-controlled crossover study( Reference Trautvetter and Jahreis 8 ). Trautvetter and Jahreis( Reference Trautvetter and Jahreis 8 ) suggest that Ca supplementation stimulates the secretion of gastrointestinal hormones (GLP-1 and GLP-2) through the modulation of the intestinal environment. GLP-2 has trophic effects in the intestinal mucosa and influences the tight-junction gene expression (occludin and ZO-1)( Reference Dong, Zhao and Solomon 90 ). On the other hand, Metzler-Zebeli et al.( Reference Metzler-Zebeli, Mann and Ertl 91 ) observed a substantial down-regulation of occludin and ZO-1 protein expression in the jejunum of weaned pigs (n 8 per group) fed high-Ca diets (14·8 g Ca/kg) as compared with adequate-Ca diets (8·2 g/kg), whereas gene expression in the colon was unaffected by dietary Ca concentration. The authors suggest that alterations in gene expression were not translated into functional protein, as they did not observe higher intestinal permeability, measured by an enhanced serum acute-phase response or intestinal translocation of LPS( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 , Reference Metzler-Zebeli, Mann and Ertl 91 ).

LPS or serum anti-endotoxin antibodies, gut barrier disintegration and endotoxaemia markers were lower after high-Ca diets than after the control diet in mice( Reference Schepens, Schonewille and Vink 51 , Reference Van Ampting, Schonewille and Vink 52 ) (but not in pigs)( Reference Metzler-Zebeli, Mann and Schmitz-Esser 59 ) (120 mmol Ca/kg( Reference Schepens, Schonewille and Vink 51 ), 4·8( Reference Van Ampting, Schonewille and Vink 52 ) or 14·8 g/kg diet( Reference Van Ampting, Schonewille and Vink 52 )). Moreover, Ca supplementation reduced bacterial translocation after Salmonella infection, indicating increased mucosal integrity( Reference Bovee-Oudenhoven, Termont and Weerkamp 27 , Reference Bovee-Oudenhoven, Wissink and Wouters 38 , Reference Ten Bruggencate, Bovee-Oudenhoven and Lettink-Wissink 50 , Reference Van Ampting, Schonewille and Vink 52 ). However, we emphasise that differences in circulating endotoxin or bacteria may also reflect differences in detoxification or post-absorption clearance. Therefore, it is not related to intestinal translocation only( Reference Creely, McTernan and Kusminski 92 , Reference Moreira, Texeira and Ferreira 93 ).

Metabolic endotoxaemia, characterised by moderately elevated serum levels of LPS, is associated with obesity, T2DM and IR( Reference Cani, Possemiers and Van de Wiele 10 , Reference Cani, Amar and Iglesias 20 ). High-fat diets, which are generally associated with obesity, also seem to induce a reduction in II and low-grade endotoxaemia( Reference Mani, Hollis and Gabler 94 ). The factors involved in II breakdown in obese patients mainly consist of dysbiosis, adoption of dietary pattern characterised by foods rich in fat and fructose and deficiencies in the intake of nutrients( Reference Teixeira, Collado and Ferreira 95 ). In congruence with the mechanisms discussed in this review, we consider that the effects of Ca on II may involve gut microbiota and bacterial fermentation product modulation, in addition to direct action on tight junctions and a decrease in luminal cytotoxicity. For example, butyrate enhances the intestinal barrier because it facilitates the assembly of tight junctions( Reference Ulluwishewa, Anderson and McNabb 96 ). It is possible that a high-Ca (>1100 mg/d in the human studies selected for this review( Reference Govers, Termont and Lapre´ 41 , Reference Trautvetter, Ditscheid and Kiehntopf 43 )) intake contributes to the maintenance of II, especially in the obese. However, because no human clinical trials have been conducted to date, it is not possible to confirm this association yet.

Conclusions

Dietary Ca appears to positively affect gut microbiota composition and II, which may improve obesity and T2DM treatment. The mechanisms suggested involve BA and FA precipitation and, consequently, a decrease in luminal cytotoxicity, lactobacilli growth and intestinal mucosal damage reduction. Ca appears to affect colon integrity to a great degree, and the amount of phosphate in the diet or the source of the Ca supplement appears to have minimal effect. PUFA faecal excretion seems to be lower than SFA excretion.

To our knowledge, the contribution of this modulation to the control of obesity and diabetes mellitus is uncertain. Further human clinical trials are needed to explore the potential of dietary Ca or Ca salt supplementation in the modulation of microbiota and intestinal barrier integrity and to ultimately determine the applicability of relatively simple dietary interventions to the treatment of chronic diseases. Further research is required to define the supplementation period, the dose and the type of Ca supplement (milk or salt) that is more effective in healthy, obese and diabetic subjects. As Ca interacts with other components of the diet, these interactions should also be considered in future research. We believe that more complex mechanisms involving extraintestinal disorders (hormones, cytokines and other biomarkers) also need to be studied.

Acknowledgements

The authors thank Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

The authors’ contributions were as follows: J. M. G. G., J. A. C. and R. C. A. designed the concept of the study, and all authors were involved in the literature search and review. J. M. G. G. and J. A. C. wrote the manuscript. J. M. G. G., J. A. C. and R. C. A. were involved with editing the manuscript, and all authors read and approved the final manuscript.

None of the authors has any conflicts of interest to declare.

Supplementary material

For supplementary material/s referred to in this article, please visit http://dx.doi.org/doi:10.1017/S0007114515003608

References

1. Miller, GD, Jarvis, JK & McBean, LD (2001) The importance of meeting calcium needs with foods. J Am Coll Nutr 20, 168S185S.Google Scholar
2. Ferreira, TS, Torres, MRS & Sanjuliani, AF (2013) Dietary calcium intake is associated with adiposity, metabolic profile, inflammatory state and blood pressure, but not with erythrocyte intracellular calcium and endothelial function in healthy pre-menopausal women. Br J Nutr 110, 10791088.Google Scholar
3. Pittas, AG, Lau, J, Hu, FB, et al. (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 20172029.CrossRefGoogle ScholarPubMed
4. Zemel, MB, Shi, H, Greer, B, et al. (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 11321138.Google Scholar
5. Jacobsen, R, Lorenzen, J, Toubro, S, et al. (2005) Effect of short- term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes 29, 292301.CrossRefGoogle ScholarPubMed
6. Youn, JH, Gulve, EA & Holloszy, JO (1991) Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Cell Physiol 260, C555C561.CrossRefGoogle ScholarPubMed
7. Gilon, P, Chae, HY, Rutter, GA, et al. (2014) Calcium signaling in pancreatic β-cells in health and in type 2 diabetes. Cell Calcium 56, 340361.CrossRefGoogle ScholarPubMed
8. Trautvetter, U & Jahreis, G (2014) Effect of supplementary calcium phosphate on plasma gastrointestinal hormones in a double-blind, placebo-controlled, cross-over human study. Br J Nutr 111, 287293.CrossRefGoogle Scholar
9. Cani, PD, Bibiloni, R, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 14701481.Google Scholar
10. Cani, PD, Possemiers, S, Van de Wiele, T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 10911103.CrossRefGoogle ScholarPubMed
11. Larsen, N, Vogensen, FK, van den Berg, FW, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5, e9085.CrossRefGoogle ScholarPubMed
12. Wu, X, Ma, C, Han, L, et al. (2010) Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 61, 6978.CrossRefGoogle ScholarPubMed
13. Frazier, TH, DiBaise, JK & McClain, CJ (2011) Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr 35, 14S20S.Google Scholar
14. Moreno-Indias, I, Cardona, F, Tinahones, FJ, et al. (2014) Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 5, 190.Google Scholar
15. Odenwald, MA & Turner, JR (2013) Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 11, 10751083.Google Scholar
16. Natividad, JM & Verdu, EF (2013) Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res 69, 4251.Google Scholar
17. Teixeira, TFS, Moreira, APB, Silva, NCS, et al. (2014) Intestinal permeability measurements: general aspects and possible pitfalls. Nutr Hosp 29, 269281.Google Scholar
18. Lopetuso, LR, Scaldaferri, F, Bruno, G, et al. (2015) The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. Eur Rev Med Pharmacol Sci 19, 10681076.Google Scholar
19. Musso, G, Gambino, R & Cassader, M (2010) Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 33, 22772284.CrossRefGoogle ScholarPubMed
20. Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 17611772.CrossRefGoogle ScholarPubMed
21. Ley, RE, Turnbaugh, PJ, Klein, S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 10221023.Google Scholar
22. Turnbaugh, PJ, Hamady, M, Yatsunenko, T, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457, 480484.Google Scholar
23. Jayashree, B, Bibin, YS, Prabhu, D, et al. (2014) Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 388, 203210.CrossRefGoogle ScholarPubMed
24. Imamura, F, Micha, R, Khatibzadeh, S, et al. (2015) Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health 3, e132e142.Google Scholar
25. David, LA, Maurice, CF, Carmody, RN, et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559563.CrossRefGoogle ScholarPubMed
26. Bovee-Oudenhoven, I, Termont, D, Dekker, R, et al. (1996) Calcium in milk and fermentation by yoghurt bacteria increase the resistance of rats to Salmonella infection. Gut 38, 5965.CrossRefGoogle ScholarPubMed
27. Bovee-Oudenhoven, IM, Termont, DS, Weerkamp, AH, et al. (1997) Dietary calcium inhibits the intestinal colonization and translocation of Salmonella in rats. Gastroenterology 113, 550557.Google Scholar
28. Kopic, S & Geibel, JP (2013) Gastric acid, calcium absorption, and their impact on bone health. Physiol Rev 93, 189268.Google Scholar
29. Álvarez-Ordóñez, A, Begley, M, Prieto, M, et al. (2011) Salmonella spp. survival strategies within the host gastrointestinal tract. Microbiology 157, 32683281.Google Scholar
30. Sarker, SA & Gyr, K (1992) Non-immunological defence mechanisms of the gut. Gut 33, 987993.Google Scholar
31. Zhu, H, Hart, CA & Sales, D (2006) Bacterial killing in gastric juice – effect of pH and pepsin on Escherichia coli and Helicobacter pylori . J Med Microbiol 55, 12651270.Google Scholar
32. Berg, RD (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4, 430435.CrossRefGoogle ScholarPubMed
33. Dicksved, J, Lindberg, M, Rosenquist, M, et al. (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58, 509516.Google Scholar
34. Mills, S, Ross, RP, Hill, C, et al. (2011) Milk intelligence: mining milk for bioactive substances associated with human health. Int Dairy J 21, e401.Google Scholar
35. Venema, K (2012) Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J 22, 123140.Google Scholar
36. Lapré, JA, De Vries, HT, Koeman, JH, et al. (1993) The antiproliferative effect of dietary calcium on colonic epithelium is mediated by luminal surfactants and dependent on the type of dietary fat. Cancer Res 53, 784789.Google Scholar
37. Govers, MJ, Termont, DS & Van der Meer, R (1994) Mechanism of the antiproliferative effect of milk mineral and other calcium supplements on colonic epithelium. Cancer Res 54, 95100.Google Scholar
38. Bovee-Oudenhoven, IMJ, Wissink, MLG, Wouters, JTM, et al. (1999) Dietary calcium phosphate stimulates intestinal lactobacilli and decreases the severity of a Salmonella infection in rats. J Nutr 129, 607612.Google Scholar
39. Van der Meer, R, Welberg, JWM, Kuipers, F, et al. (1990) Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology 99, 16531659.Google Scholar
40. Govers, MJ & Van der Meer, R (1993) Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 34, 365370.Google Scholar
41. Govers, MJAP, Termont, DSML, Lapre´, JA, et al. (1996) Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res 56, 32703275.Google Scholar
42. Ditscheid, B, Keller, S & Jahreis, G (2009) Faecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differences. Eur J Nutr 48, 2230.CrossRefGoogle ScholarPubMed
43. Trautvetter, U, Ditscheid, B, Kiehntopf, M, et al. (2012) A combination of calcium phosphate and probiotics beneficially influences intestinal lactobacilli and cholesterol metabolism in humans. Clin Nutr 31, 230237.Google Scholar
44. Zheng, H, Yde, CC, Clausen, MR, et al. (2015) Metabolomics investigation to shed light on cheese as a possible piece in the French paradox puzzle. J Agric Food Chem 63, 28302839.Google Scholar
45. Begley, M, Gahan, CG & Hill, C (2005) The interaction between bacteria and bile. FEMS Microbiol Rev 29, 625651.Google Scholar
46. Floch, MH (2002) Bile salts, intestinal microbiota and enterohepatic circulation. Digest Liver Dis 34, S54e7.Google Scholar
47. Schepens, MA, ten Bruggencate, SJ, Schonewille, AJ, et al. (2012) The protective effect of supplemental calcium on colonic permeability depends on a calcium phosphate-induced increase in luminal buffering capacity. Br J Nutr 107, 950956.Google Scholar
48. Roberton, AM (1993) Roles of endogenous substances and bacteria in colorectal cancer. Mutation Res 290, 7178.Google Scholar
49. Lapré, JA, Termont, DS, Groen, AK, et al. (1992) Lytic effects of mixed micelles of fatty acids and bile acids. Am J Physiol. 263, G333G337.Google Scholar
50. Ten Bruggencate, SJ, Bovee-Oudenhoven, IM, Lettink-Wissink, ML, et al. (2004) Dietary fructo-oligosaccharides and inulin decrease resistance of rats to Salmonella: protective role of calcium. Gut 53, 530535.Google Scholar
51. Schepens, MA, Schonewille, AJ, Vink, C, et al. (2009) Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. J Nutr 139, 15251533.Google Scholar
52. Van Ampting, MT, Schonewille, AJ, Vink, C, et al. (2010) Damage to the intestinal epithelial barrier by antibiotic pretreatment of Salmonella-infected rats is lessened by dietary calcium or tannic acid. J Nutr 140, 21672172.Google Scholar
53. Ajouz, H, Mukherji, D & Shamseddine, A (2014) Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol 12, 164.Google Scholar
54. Guarner, F (2007) Studies with inulin-type fructans on intestinal infections, permeability, and inflammation. J Nutr 137, 2568S2571S.Google Scholar
55. Christensen, R, Lorenzen, JK, Svith, CR, et al. (2009) Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 10, 475486.Google Scholar
56. Ten Bruggencate, SJ, Snel, J, Schoterman, MH, et al. (2011) Efficacy of various dietary calcium salts to improve intestinal resistance to Salmonella infection in rats. Br J Nutr 105, 489495.Google Scholar
57. Metzler-Zebeli, BU, Vahjen, W, Baumgärtel, T, et al. (2010) Ileal microbiota of growing pigs fed different dietary calcium phosphate levels and phytase content and subjected to ileal pectin infusion. J Anim Sci 88, 147158.Google Scholar
58. Metzler-Zebeli, BU, Zijlstra, RT, Mosenthin, R, et al. (2011) Dietary calcium phosphate content and oat β-glucan influence gastrointestinal microbiota, butyrate-producing bacteria and butyrate fermentation in weaned pigs. FEMS Microbiol Ecol 75, 402413.Google Scholar
59. Metzler-Zebeli, BU, Mann, E, Schmitz-Esser, S, et al. (2013) Changing dietary calcium-phosphorus level and cereal source selectively alters abundance of bacteria and metabolites in the upper gastrointestinal tracts of weaned pigs. Appl Environ Microbiol 79, 72647272.Google Scholar
60. Mann, E, Schmitz-Esser, S, Zebeli, Q, et al. (2014) Mucosa-associated bacterial microbiome of the gastrointestinal tract of weaned pigs and dynamics linked to dietary calcium-phosphorus. PLOS ONE 9, e86950.Google Scholar
61. Kim, SW, Suda, W, Kim, S, et al. (2013) Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 20, 241253.Google Scholar
62. Louis, P & Flint, HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294, 18.Google Scholar
63. Ottman, N, Smidt, H, de Vos, WM, et al. (2012) The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2, 104.Google Scholar
64. Nicholson, JK, Holmes, E, Kinross, J, et al. (2012) Host-gut microbiota metabolic interactions. Science 336, 12621267.CrossRefGoogle ScholarPubMed
65. Ridaura, VK, Faith, JJ, Rey, FE, et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214.Google Scholar
66. Ley, RE (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26, 511.Google Scholar
67. Schepens, MA, Rijnierse, A, Schonewille, AJ, et al. (2010) Dietary calcium decreases but short-chain fructo-oligosaccharides increase colonic permeability in rats. Br J Nutr 104, 17801786.Google Scholar
68. Fooks, LJ & Gibson, GR (2002) Probiotics as modulators of the gut flora. Br J Nutr 88, S39S49.Google Scholar
69. Bronner, F (2009) Recent developments in intestinal calcium absorption. Nutr Rev 67, 109113.Google Scholar
70. Overduin, J, Schoterman, MH, Calame, W, et al. (2013) Dietary galacto-oligosaccharides and calcium: effects on energy intake, fat-pad weight and satiety-related, gastrointestinal hormones in rats. Br J Nutr 109, 13381348.Google Scholar
71. Whisner, CM, Martin, BR, Schoterman, MH, et al. (2013) Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. Br J Nutr 110, 12921303.Google Scholar
72. Weaver, CM, Martin, BR, Nakatsu, CH, et al. (2011) Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J Agric Food Chem 59, 65016510.Google Scholar
73. Van Langen, MAC & Dieleman, LA (2009) Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis 15, 454462.Google Scholar
74. Pryde, SE, Duncan, SH, Hold, GL, et al. (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133139.CrossRefGoogle ScholarPubMed
75. Canani, RB, Costanzo, MD, Leone, L, et al. (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17, 15191528.Google Scholar
76. Louis, P, Scott, KP, Duncan, SH, et al. (2007) Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102, 11971208.Google Scholar
77. Duncan, SH, Louis, P & Flint, HJ (2007) Cultivable bacterial diversity from the human colon. Lett Appl Microbiol 44, 343350.Google Scholar
78. Schwiertz, A, Taras, D, Schafer, K, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190195.Google Scholar
79. Musso, G, Gambino, R & Cassader, M (2011) Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62, 361380.Google Scholar
80. Schepens, MA, Vink, C, Schonewille, AJ, et al. (2011) Supplemental antioxidants do not ameliorate colitis development in HLA-B27 transgenic rats despite extremely low glutathione levels in colonic mucosa. Inflamm Bowel Dis 17, 20652075.Google Scholar
81. Rao, JP (2009) Influence of dietary calcium content on intestinal permeability in rat. Indian J Med Res 129, 681684.Google Scholar
82. Arrieta, MC, Bistritz, L & Meddings, JB (2006) Alterations in intestinal permeability. Gut 55, 15121520.Google Scholar
83. Teixeira, TFS, Souza, NCS, Chiarello, PG, et al. (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31, 735740.Google Scholar
84. Vilela, EG, Torres, HOG, Ferrari, MLA, et al. (2008) Gut permeability to lactulose and mannitol differs in treated Crohn’s disease and celiac disease patients and healthy subjects. Braz J Med Biol Res 41, 1105e9.CrossRefGoogle ScholarPubMed
85. Gonzalez-Mariscal, L, Contreras, RG, Bolivar, JJ, et al. (1990) Role of calcium in tight junction formationbetween epithelial cells. Am J Physiol 259, C978C986.Google Scholar
86. Gumbiner, BM (1996) Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84, 345357.Google Scholar
87. Farquhar, MG & Palade, GE (1963) Junctional complexes in various epithelia. J Cell Biol 17, 375412.Google Scholar
88. Hwang, I, Yang, H, Kang, HS, et al. (2013) Alteration of tight junction gene expression by calcium- and vitamin D-deficient diet in the duodenum of calbindin-null mice. Int J Mol Sci 14, 2299723010.Google Scholar
89. McVey Neufeld, KA, Perez-Burgos, A, Mao, YK, et al. (2015) The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin. Neurogastroenterol Motil 27, 12534.Google Scholar
90. Dong, CX, Zhao, W, Solomon, C, et al. (2014) The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function. Endocrinology 155, 370379.Google Scholar
91. Metzler-Zebeli, BU, Mann, E, Ertl, R, et al. (2015) Dietary calcium concentration and cereals differentially affect mineral balance and tight junction proteins expression in jejunum of weaned pigs. Br J Nutr 113, 10191031.Google Scholar
92. Creely, SJ, McTernan, PG, Kusminski, CM, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740E747.Google Scholar
93. Moreira, AP, Texeira, TF, Ferreira, AB, et al. (2012) Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108, 801809.Google Scholar
94. Mani, V, Hollis, JH & Gabler, NK (2013) Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab 10, 6.CrossRefGoogle ScholarPubMed
95. Teixeira, TF, Collado, MC, Ferreira, CL, et al. (2012) Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 32, 637647.Google Scholar
96. Ulluwishewa, D, Anderson, RC, McNabb, WC, et al. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141, 769776.Google Scholar
Figure 0

Fig. 1 Possible mechanisms explaining the effects of high-calcium diets on intestinal integrity and gut microbiota. High-calcium diets seem to change the intestinal environment through the following mechanisms: (1) increasing gastric secretion leading to increased gastric pH and reduced number of viable bacteria; (2) causing bile acid and fatty acid precipitation, increasing colonic pH and reducing cytotoxic components (especially NEFA and ionised secondary bile acids) that damage the epithelial cells; and (3) increasing glucagon-like peptide-2 (GLP-2) secretion, which has a trophic effect on intestinal mucosa and reduces gene expression of tight junctions (occludin and zonula occludens-1). These mechanisms may reduce bacterial and lipopolysaccharide (LPS) translocation, by bacterial fermentation and intestinal microbiota modulation, leading to a highly selective and controlled intestinal permeability.

Supplementary material: File

Gomes supplementary material S1

Supplementary Table

Download Gomes supplementary material S1(File)
File 37.4 KB